2'-chloro-2'-deoxyadenosine has been researched along with Histiocytosis, Langerhans-Cell in 1 studies
*Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arceci, RJ; Braier, J; Donadieu, J; Egeler, RM; Grois, N; Ladisch, S; Pötschger, U; Webb, D; Weitzman, S; Whitlock, J | 1 |
1 trial(s) available for 2'-chloro-2'-deoxyadenosine and Histiocytosis, Langerhans-Cell
| Article | Year |
|---|---|
2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Topics: 2-Chloroadenosine; Antimetabolites; Deoxyadenosines; Female; Histiocytes; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Prospective Studies; Risk; Salvage Therapy; Treatment Outcome | 2009 |